Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Qualitest Pharmaceuticals, a wholly owned subsidiary of Endo Pharmaceuticals, has received US Food & Drug Administration's (FDA) approval for Toresmide tablets (generic Demadex) in 5mg, 10mg, 20mg and 100mg strengths.
Subscribe to our email newsletter
The drug has been approved as a treatment for endema associated with congestive heart failure, renal disease, or hepatic disease.
Qualitest Pharma said the FDA’s approval for Toresmide tablets is also for the treatment of hypertension alone or in combination with other antihypertensive agents.